Form 8-K · Current report
News Corp 8-K, filed Aug 17, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000181
Summary
News Corp disclosed in an SEC filing that it bought back 58,482 Class A common shares on 14 August 2026 for about US$1.7 million, bringing cumulative repurchases under its 2025 Repurchase Program to roughly US$425.9 million of the US$1 billion authorized in July 2025.
Key points
- News Corp repurchased 58,482 Class A shares on 14 August 2026 at prices between US$28.87 and US$29.25, for total consideration of about US$1,697,674.
- Cumulative repurchases under the program total 10,783,668 shares for about US$276.1 million in consideration paid.
- The buy-back program, authorized 15 July 2025, permits up to US$1 billion of Nasdaq-listed Class A and Class B common stock; no ASX-listed CDIs are being repurchased.
- The filing was made as a daily buy-back notification to the Australian Securities Exchange, where News Corp trades under the code NWS.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.